Accelerated epigenetic aging in Down syndrome

Down Syndrome (DS) entails an increased risk of many chronic diseases that are typically associated with older age. The clinical manifestations of accelerated aging suggest that trisomy 21 increases the biological age of tissues, but molecular evidence for this hypothesis has been sparse. Here, we utilize a quantitative molecular marker of aging (known as the epigenetic clock) to demonstrate that trisomy 21 significantly increases the age of blood and brain tissue (on average by 6.6 years, P = 7.0 × 10−14).

[1]  Hong Gu,et al.  Increased “absence” of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome , 2008, Neuroscience Letters.

[2]  J. Skurnick,et al.  Proliferation dynamics in cultured skin fibroblasts from Down syndrome subjects. , 2005, Free Radical Biology & Medicine.

[3]  H. Hampel,et al.  Neuroanatomy of Down Syndrome in vivo: A Model of Preclinical Alzheimer’s Disease , 2006, Behavior genetics.

[4]  Wolfgang Wagner,et al.  Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. , 2010, Genome research.

[5]  W. Zigman.  Atypical aging in Down syndrome. , 2013, Developmental disabilities research reviews.

[6]  Steve Horvath,et al.  Obesity accelerates epigenetic aging of human liver , 2014, Proceedings of the National Academy of Sciences.

[7]  N. Schork,et al.  Altered DNA Methylation in Leukocytes with Trisomy 21 , 2010, PLoS genetics.

[8]  T. Ideker,et al.  Genome-wide methylation profiles reveal quantitative views of human aging rates. , 2013, Molecular cell.

[9]  E. Head,et al.  Alzheimer disease and Down syndrome: factors in pathogenesis , 2005, Neurobiology of Aging.

[10]  M. Cynader,et al.  Distinct DNA methylation patterns of cognitive impairment and trisomy 21 in down syndrome , 2013, BMC Medical Genomics.

[11]  C B Harley,et al.  Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. , 1993, American journal of human genetics.

[12]  Anthony P. Fejes,et al.  DNA methylation, genotype and gene expression: who is driving and who is along for the ride? , 2013, Genome Biology.

[13]  R. Folkerth,et al.  Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury. , 2008, Human molecular genetics.

[14]  D. C. Cabelof,et al.  Down syndrome as a model of DNA polymerase beta haploinsufficiency and accelerated aging , 2012, Mechanisms of Ageing and Development.

[15]  E. Andres Houseman,et al.  Reference-free cell mixture adjustments in analysis of DNA methylation data , 2014, Bioinform..

[16]  S. Horvath,et al.  Aging effects on DNA methylation modules in human brain and blood tissue , 2012, Genome Biology.

[17]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[18]  E. Cuadrado,et al.  Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system? , 1996, Clinical immunology and immunopathology.

[19]  Stylianos E. Antonarakis,et al.  Domains of genome-wide gene expression dysregulation in Down’s syndrome , 2014, Nature.

[20]  R. Verstegen,et al.  Down syndrome: is it really characterized by precocious immunosenescence? , 2011, Aging and disease.

[21]  A. Ciccodicola,et al.  Massive-Scale RNA-Seq Analysis of Non Ribosomal Transcriptome in Human Trisomy 21 , 2011, PloS one.

[22]  J. Wegiel,et al.  Dementia of the Alzheimer's type and accelerated aging in Down syndrome. , 2005, Science of aging knowledge environment : SAGE KE.